Biologix

Biologix, a **Brazil**-based startup founded in **2015**, is revolutionizing the way sleep apnea is diagnosed with its home sleep apnea test, Oxistar. The company's slogan "Saúde do sono na ponta do dedo" emphasizes their commitment to making sleep health accessible to all. By simply wearing the Oxistar sensor on a finger before going to bed and using the Biologix app, users can effortlessly conduct the sleep apnea test at home. Upon waking up, the test results are available within seconds, providing quick and convenient insights into sleep quality. In its latest funding round on **07 May 2024**, Biologix secured a notable **$1.20M** investment from prominent investors including **Kortex Ventures** and **Hospital Israelita Albert Einstein**. This investment signifies growing interest and confidence from leading players in the health care and SaaS industries, acknowledging Biologix's potential to disrupt the sleep health market. With its innovative approach to at-home sleep testing and strong investor backing, Biologix is poised to make a significant impact on the health care industry. Its focus on accessibility and simplicity aligns with evolving consumer preferences, positioning the company for sustained growth and success in the years ahead.